We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
A recent study has bolstered research demonstrating the inimitable value of GE Healthcare’s Invenia ABUS in supplementing mammography in the detection of breast cancer. Here, the benefits are outlaid and the future of breast screening defined.